Skip to main content

Otitis Media With Effusion

1
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
1
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Integra LifeSciences
Integra LifeSciencesAustralia - Clayton
2 programs
1
tympanostomy tubePhase 2/31 trial
Acclarent Tympanostomy Tube Delivery SystemN/A1 trial
Active Trials
NCT00939796Completed16Est. Jul 2009
NCT01202578Completed53Est. Dec 2010

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Integra LifeSciencestympanostomy tube
Integra LifeSciencesAcclarent Tympanostomy Tube Delivery System

Clinical Trials (2)

Total enrollment: 69 patients across 2 trials

Evaluation of the Tympanostomy Tube Delivery System

Start: Sep 2010Est. completion: Dec 201053 patients
Phase 2/3Completed
NCT00939796Integra LifeSciencesAcclarent Tympanostomy Tube Delivery System

Clinical Study of the Tympanostomy Tube Delivery System

Start: Mar 2009Est. completion: Jul 200916 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.